Journal ArticleJ Healthc Manag · May 2021
Accountable care organizations (ACOs) need confidence in their return on investment to implement changes in care delivery that prioritize seriously ill and high-cost Medicare beneficiaries. The objective of this study was to characterize spending on seriou ...
Full textLink to itemCite
Journal ArticleAm J Manag Care · December 2020
OBJECTIVES: Since 2019, the Medicare Shared Savings Program (MSSP) has allowed accountable care organizations (ACOs) to choose either retrospectively or prospectively attributed ACO populations. To understand how ACOs' choice of attribution method affects ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · February 5, 2019
Background The 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guideline increased the number of primary prevention patients eligible for statin therapy, yet uptake of these guidelines has been modest. Little is known o ...
Full textLink to itemCite
Journal ArticleCase Rep Med · 2019
We present a case of a young lady with extreme involuntary weight loss and alarming constitutional symptoms found ultimately to be all due to a single medication's side effects. The objective of this case report is to alert physicians, especially in a prim ...
Full textLink to itemCite
Journal ArticleAm J Manag Care · October 2017
OBJECTIVES: Hospitals have rapidly acquired medical oncology practices in recent years. Experts disagree as to whether these trends are related to oncology-specific market factors or reflect a general trend of hospital-physician integration. The objective ...
Link to itemCite
Journal ArticleJ Gen Intern Med · November 2016
BACKGROUND: Multiple payment reform efforts are under way to improve the value of care delivered to Medicare beneficiaries, yet few directly address the interface between primary and specialty care. OBJECTIVE: To describe regional variation in outpatient v ...
Full textLink to itemCite
Journal ArticleJ Oncol Pract · October 2016
PURPOSE: To determine the relationships between hospital use of treating oncology practices and patient outcomes. PATIENTS AND METHODS: Retrospective analysis of 397,646 Medicare beneficiaries who received anticancer therapy in 2012. Each beneficiary was a ...
Full textLink to itemCite
Journal ArticleHealthc (Amst) · September 2016
BACKGROUND: Efforts to improve the efficiency of care for the Medicare population commonly target high cost beneficiaries. We describe and evaluate a novel management approach, population segmentation, for identifying and managing high cost beneficiaries. ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · February 23, 2016
BACKGROUND: Utilization of cardiac services varies across regions and hospitals, yet little is known regarding variation in the intensity of outpatient cardiac care across cardiology physician practices or the association with clinical endpoints, an area o ...
Full textOpen AccessLink to itemCite
Journal ArticleBreast Cancer Res Treat · June 2015
Studies have suggested a decreased breast cancer risk in women with systemic lupus erythematosus. However, these studies enrolled younger patients identified primarily from lupus clinics. We compared the 5-year incidence of breast cancer among women with a ...
Full textLink to itemCite
Journal ArticleHealth Aff (Millwood) · April 2015
In recent years many policy makers have recommended alternative payment models in medical oncology in order to reduce costs and improve patient outcomes. Yet information on how oncology practices differ in their use of key service categories is limited. We ...
Full textLink to itemCite
Journal ArticleNeurology · March 10, 2009
OBJECTIVE: The American Headache Society developed an innovative Web-based neurology resident educational program to 1) meet the objectives of the Accreditation Council for Graduate Medical Education Outcomes Project; 2) provide measurable improvement of a ...
Full textLink to itemCite
Journal ArticleCurr Med Res Opin · March 2008
OBJECTIVE: Previous labeling and guidelines recommended initiating erythropoiesis agents (ESAs) for chemotherapy-induced anemia (CIA) at hemoglobin (Hb) levels < 11 g/dL, maintaining near 12 g/dL, and withholding at > or = 13 g/dL. This study analyzed adhe ...
Full textLink to itemCite